Alnylam Pharmaceuticals Inc (ALNY)
NASDAQ · Healthcare
Alnylam Pharmaceuticals Inc Income Statement 2008–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2010 | Dec 2009 | Dec 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||
| Revenue | 3.71B | 2.25B | 1.83B | 1.04B | 844.3M | 492.9M | 219.8M | 74.9M | 89.9M | 47.2M | 100.0M | 100.5M | 96.2M |
| Gross Profit | 3.04B | 1.94B | 1.56B | 897.2M | 729.3M | 418.7M | 194.7M | 73.1M | 89.9M | — | — | — | — |
| Profitability | |||||||||||||
| Operating Income | 501.6M | -176.9M | -282.2M | -785.1M | -708.7M | -828.4M | -939.4M | -814.7M | -500.1M | -424.6M | -44.1M | -48.1M | -27.8M |
| EBITDA | 557.2M | -120.2M | -228.1M | -740.6M | -661.1M | -793.7M | -922.3M | -799.4M | -486.7M | -409.5M | -39.1M | -42.1M | -22.1M |
| Net Income | 313.7M | -278.2M | -440.2M | -1.13B | -852.8M | -858.3M | -886.1M | -761.5M | -490.9M | -410.1M | -43.5M | -47.6M | -26.2M |
| Per Share Data | |||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 135M | 128M | 125M | 122M | 118M | 115M | 109M | 101M | 100M | 86M | 42M | 42M | — |
Alnylam Pharmaceuticals Inc Income Statement — FAQ
Alnylam Pharmaceuticals Inc (ALNY) income statement over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALNY's income statement history?
The chart and table above show Alnylam Pharmaceuticals Inc's income statement by year and by quarter, including the growth rate.